Great result for IMU, beating market leader Herceptin at relevant stage of development, Ph2.
Had expected a bit of slip stream but someone decided to dump. Congrats to those catching the sub 9c today, will make them a good profit LT.
Not an If, just a When, CHM will have similar news in the coming months / years for their treatments.
GLTA
Ann: First phase 1B trial of NK cells with IL-2 & Vactosertib, page-22
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
-0.002(13.0%) |
Mkt cap ! $9.951M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.1¢ | 1.0¢ | $7.48K | 687.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2626306 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.1¢ | 189548 | 5 |
View Market Depth
| Last trade - 10.58am 07/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |